
[Federal Register Volume 76, Number 45 (Tuesday, March 8, 2011)]
[Rules and Regulations]
[Page 12563]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5147]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 1, 14, and 17

[Docket No. FDA-2010-N-0560]
RIN 0910-AG55


Amendments to General Regulations of the Food and Drug 
Administration; Confirmation of Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of April 14, 2011, for the final rule that appeared in 
the Federal Register of November 30, 2010 (75 FR 73951). The direct 
final rule amends certain general regulations of FDA to include tobacco 
products, where appropriate, in light of FDA's authority to regulate 
these products under the Family Smoking Prevention and Tobacco Control 
Act, by revising the Agency's regulations to require tobacco products 
to be subject to the same general requirements that apply to other FDA-
regulated products. This document confirms the effective date of the 
direct final rule.

DATES: Effective date confirmed: April 14, 2011.

FOR FURTHER INFORMATION CONTACT: Gerie A. Voss, Center for Tobacco 
Products, Food and Drug Administration, 9200 Corporate Blvd., rm. 204G, 
Rockville, MD 20850, 1-877-CTP-1373.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 30, 2010 
(75 FR 73951), FDA solicited comments concerning the direct final rule 
for a 75-day period ending February 14, 2011. FDA stated that the 
effective date of the direct final rule would be on April 14, 2011, 60 
days after the end of the comment period, unless any significant 
adverse comment was submitted to FDA during the comment period. FDA did 
not receive any significant adverse comments.

    Authority:  Therefore, under the Federal Food, Drug, and 
Cosmetic Act and under authority delegated to the Commissioner of 
Food and Drugs, 21 CFR parts 1, 14, and 17 are amended. Accordingly, 
the amendments issued thereby are effective.

    Dated: March 2, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-5147 Filed 3-7-11; 8:45 am]
BILLING CODE 4160-01-P


